Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank93
3Y CAGR+32.5%
5Y CAGR+182.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+32.5%/yr
Annual compound
5Y CAGR
+182.4%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
179.5x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.59 | +271.0% |
| 2024 | 0.16 | -45.2% |
| 2023 | 0.29 | +14.4% |
| 2022 | 0.25 | +6119.2% |
| 2021 | 0.00 | +24.1% |
| 2020 | 0.00 | +101.8% |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |